Affordable Access

Publisher Website

Adiposopathy and bariatric surgery: is ‘sick fat’ a surgical disease?

Authors
Journal
International Journal of Clinical Practice
1368-5031
Publisher
Wiley Blackwell (Blackwell Publishing)
Publication Date
Volume
63
Issue
9
Identifiers
DOI: 10.1111/j.1742-1241.2009.02151.x
Keywords
  • Consensus
Disciplines
  • Medicine

Abstract

Objective: To review how bariatric surgery in obese patients may effectively treat adiposopathy (pathogenic adipose tissue or ‘sick fat’), and to provide clinicians a rationale as to why bariatric surgery is a potential treatment option for overweight patients with type 2 diabetes, hypertension, and dyslipidaemia. Methods: A group of clinicians, researchers, and surgeons, all with a background in treating obesity and the adverse metabolic consequences of excessive body fat, reviewed the medical literature regarding the improvement in metabolic disease with bariatric surgery. Results: Bariatric surgery improves metabolic disease through multiple, likely interrelated mechanisms including: (i) initial acute fasting and diminished caloric intake inherent with many gastrointestinal surgical procedures; (ii) favourable alterations in gastrointestinal endocrine and immune responses, especially with bariatric surgeries that reroute nutrient gastrointestinal delivery such as gastric bypass procedures; and (iii) a decrease in adipose tissue mass. Regarding adipose tissue mass, during positive caloric balance, impaired adipogenesis (resulting in limitations in adipocyte number or size) and visceral adiposity are anatomic manifestations of pathogenic adipose tissue (adiposopathy). This may cause adverse adipose tissue endocrine and immune responses that lead to metabolic disease. A decrease in adipocyte size and decrease in visceral adiposity, as often occurs with bariatric surgery, may effectively improve adiposopathy, and thus effectively treat metabolic disease. It is the relationship between bariatric surgery and its effects upon pathogenic adipose tissue that is the focus of this discussion. Conclusions: In selective obese patients with metabolic disease who are refractory to medical management, adiposopathy is a surgical disease.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Adiposopathy:Is “Sick Fat” a Cardiovascular Diseas...

on Journal of the American Colleg... Jan 01, 2011

Is adiposopathy (sick fat) an endocrine disease?

on International Journal of Clini... Oct 01, 2008

'Adiposopathy' and cardiovascular disease: the ben...

on Current opinion in cardiology September 2013

Lorcaserin and adiposopathy: 5-HT2c agonism as a t...

on Expert Review of Cardiovascula... November 2009
More articles like this..